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Comparative Utility of the BESTest,
Mini-BESTest, and Brief-BESTest for
Predicting Falls in Individuals With
Parkinson Disease: A Cohort Study
Ryan P. Duncan, Abigail L. Leddy, James T. Cavanaugh, Leland E. Dibble,
Terry D. Ellis, Matthew P. Ford, K. Bo Foreman, Gammon M. Earhart

Background. The newly developed Brief–Balance Evaluation System Test (BriefBESTest) may be useful for measuring balance and predicting falls in individuals with
Parkinson disease (PD).
Objectives. The purposes of this study were: (1) to describe the balance performance of those with PD using the Brief-BESTest, (2) to determine the relationships
among the scores derived from the 3 versions of the BESTest (ie, full BESTest,
Mini-BESTest, and Brief-BESTest), and (3) to compare the accuracy of the BriefBESTest with that of the Mini-BESTest and BESTest in identifying recurrent fallers
among people with PD.

Design. This was a prospective cohort study.
Methods. Eighty participants with PD completed a baseline balance assessment.
All participants reported a fall history during the previous 6 months. Fall history was
again collected 6 months (n⫽51) and 12 months (n⫽40) later.

Results. At baseline, participants had varying levels of balance impairment, and
Brief-BESTest scores were significantly correlated with Mini-BESTest (r⫽.94, P⬍.001)
and BESTest (r⫽.95, P⬍.001) scores. Six-month retrospective fall prediction accuracy
of the Brief-BESTest was moderately high (area under the curve [AUC]⫽0.82, sensitivity⫽0.76, and specificity⫽0.84). Prospective fall prediction accuracy over
6 months was similarly accurate (AUC⫽0.88, sensitivity⫽0.71, and specificity⫽0.87),
but was less sensitive over 12 months (AUC⫽0.76, sensitivity⫽0.53, and
specificity⫽0.93).

Limitations. The sample included primarily individuals with mild to moderate
PD. Also, there was a moderate dropout rate at 6 and 12 months.
Conclusions. All versions of the BESTest were reasonably accurate in identifying
future recurrent fallers, especially during the 6 months following assessment. Clinicians can reasonably rely on the Brief-BESTest for predicting falls, particularly when
time and equipment constraints are of concern.
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alls are common among people
with Parkinson disease (PD). A
retrospective study demonstrated that 38.3% of individuals with
PD fell since being diagnosed and
67% of fallers fell more than once
since diagnosis.1 One devastating
complication of falling is hip fracture, which is associated with high
mortality in people with PD.2,3 Other
consequences include: immobility,
reduced quality of life, and fear of
falling.4 Postural instability and
impaired gait are independently
associated with increased falls in
PD.5,6 In addition, rehabilitation
intervention trials suggest that programs targeted at fall prevention are
successful at improving postural
competence and reducing falls in
PD.7,8 As such, accurate and timeefficient measures are critically
needed to direct appropriate interventions for those at risk. Measures
to predict falls in people with PD
should be: (1) theoretically grounded
in examining the systems controlling
balance and gait, (2) accurate in their
ability to predict falls, and (3) feasible and practical for clinical use.

The Balance Evaluation Systems Test
(BESTest) was developed from a
theoretical understanding of balance
control systems. It includes 36 items
that evaluate performance of 6 balance systems: biomechanical constraints, stability limits/verticality,
anticipatory postural adjustments,
postural responses, sensory orientation, and stability in gait.9 The
BESTest was effective in determining
which individuals with PD fell in
the previous 6 months and accurate
in prospectively predicting falls 6
months from original assessment,
but was less useful for predicting
falls 12 months from original assessment.10,11 One concern regarding
the BESTest is that it can take at least
40 minutes to complete for someone
with mild PD and even longer than
40 minutes with greater disease
severity. In addition, equipment
April 2013

such as a ramp, a foam block, a meter
stick, a table, and a 2.27-kg (5-lb)
weight are necessary for the BESTest
and may not be readily available for
clinicians. These concerns suggest
that the BESTest, although measuring balance control systems and possessing reasonable accuracy in predicting falls, may not be practical for
regular use in all clinical settings.
Through psychometric analysis, a
condensed version of the BESTest,
the Mini-BESTest, was developed to
enhance clinical usefulness. The
period of time to complete the MiniBESTest is substantially shorter when
compared with the period of time to
complete the full BESTest.12 The
Mini-BESTest is useful in identifying
individuals who will fall in the next
6 months, but its accuracy over 12
months is severely diminished.11
Although the Mini-BESTest reduces
the time needed to evaluate balance,
the items included are theoretically
inconsistent with the full BESTest.
The Mini-BESTest examines only 4 of
the 6 balance systems assessed in the
full BESTest. Because of this omission, deficits in the 2 untested systems (biomechanical constraints and
stability limits/verticality) may go
undetected and unaddressed.
In response to the limitations of the
BESTest and Mini-BESTest, the BriefBESTest was recently developed.13
The Brief-BESTest is a shortened version of the full BESTest that, in contrast to the Mini-BESTest, contains
items that assess all 6 balance systems originally outlined by the original BESTest, using the original scale
for scoring items. Despite evaluating
2 additional balance systems, the
Brief-BESTest requires less administration time and less equipment than
the Mini-BESTest, which could make
the Brief-BESTest more feasible for
clinical use. The accuracy of the
Brief-BESTest in people with PD is
unknown.

The objectives of this study were:
(1) to describe balance performance
in PD using the Brief-BESTest, (2) to
determine relationships among the
3 versions of the BESTest (ie, full
BESTest, Mini-BESTest, and BriefBESTest) and relationships between
the individual items of the BriefBESTest and their related sections
of the full BESTest, and (3) to determine the accuracy of the BriefBESTest compared with the MiniBESTest and full BESTest in
retrospectively and prospectively
identifying recurrent fallers among
people with PD. We hypothesized
that Brief-BESTest scores would correlate with Mini-BESTest and BESTest
scores and that the Brief-BESTest
would be equally or more accurate
than the Mini-BESTest in identifying
recurrent fallers.

Method
Participants
Participants were recruited from
Washington University’s Movement
Disorders Center and the Volunteers
for Health database for participation
in a multicenter longitudinal study.14
Individuals were eligible for participation if diagnosed with definite
idiopathic PD (Hoehn and Yahr
[H&Y] stages I–IV).15 Potential participants were excluded if they had:
a history or presence of a neurological disorder other than PD, musculoskeletal injury limiting ability to
walk, or any other serious medical
condition. Participants agreed to
complete assessments at 3 time
points: baseline, 6 months, and 12
months. All participants provided
informed consent according to the
policies and procedures of the
Human Research Protection Office at
Washington University.
Outcome Measures
The full BESTest contains 36 items
scored from 0 to 3, with 3 representing no impairment of balance and 0
representing severely impaired balance or inability to perform a task
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without falling.9 The maximum
score is measured as a percentage of
the points scored out of 108 total
points possible. In addition, 6 subsection scores are generated, each
representing a specific balance system (biomechanical constraints, stability limits/verticality, anticipatory
postural
adjustments,
postural
responses, sensory orientation, and
stability in gait). The BESTest has
high interrater and test-retest reliability in PD.16 The BESTest requires the
following equipment: a table for sitting, a meter stick, a step stool, a
2.27-kg (5-lb) weight, a 1.36-kg (3-lb)
weight, a foam block, a ramp, an
obstacle, a stopwatch, and a relatively large walkway to complete. In
our experience, the BESTest takes at
least 40 minutes to complete when
assessing an individual with mild to
moderate PD, and more time is necessary for those with more severe PD.
The Mini-BESTest contains 14 items
from the original BESTest.17 The
items collectively represent only 4 of
the 6 balance systems identified by
the full test. In contrast to the original BESTest, each item is scored 0 to
2, with 2 representing no impairment in balance and 0 representing
severe impairment of balance. Two
items have right and left components, and the maximum total score
is 32. The Mini-BESTest has high
interrater and test-retest reliability in
PD.10 The equipment needed to
complete the Mini-BESTest includes:
a foam block, a ramp, an obstacle, a
stopwatch, and a relatively large
walkway to complete. In our experience, the Mini-BESTest takes approximately 15 minutes to conduct for
most ambulatory individuals with PD.
The Brief-BESTest is a 6-item balance
assessment containing 1 item from
each of the 6 subsections of the full
BESTest (for a copy, see Padgett et
al13). Items were chosen based on
correlational analysis. The 1 item
from each specific section of the
544
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BESTest with the strongest correlation to that total section score was
included in the Brief-BESTest.13 Each
item is administered and scored the
same as in the original test (ie, performance is rated 0 to 3, with 3 representing no balance impairment
and 0 representing severe balance
impairment or inability to perform a
task without falling).13 Because 2 of
the items in the Brief-BESTest have
left and right components, the maximum possible score for the BriefBESTest is 24. The Brief-BESTest
requires only a foam block, a stopwatch, a meter stick, and enough
space to complete the Timed “Up &
Go” Test. In our experience, the
Brief-BESTest requires approximately 10 minutes to complete with
most ambulatory individuals with
PD. The interrater reliability of the
Brief-BESTest was evaluated and
noted to be high in a mixed group
that included individuals without
neurological diagnoses and individuals with varied neurological diagnoses of PD, multiple sclerosis, stroke,
neuropathy, and essential tremor.13

ing assessment, Brief-BESTest scores
were extracted from the relevant
subset of BESTest items.

Procedure
From July 2009 to December 2009,
baseline assessments were conducted with participants on antiparkinson medication approximately 1
to 1.5 hours after medication administration. Age and sex data were collected using a custom-designed form,
which was completed by each participant. Motor symptom severity
was determined using section III of
The Movement Disorder Society–
Unified Parkinson’s Disease Rating
Scale (MDS-UPDRS III).18 Hoehn &
Yahr stage was determined as a part
of the MDS-UPDRS III assessment.
Balance performance was evaluated
by a trained physical therapist using
the full, original BESTest. A customdesigned worksheet allowed the
examiner to simultaneously record
BESTest item scores and MiniBESTest item scores, each of which
have distinct scoring scales. Follow-

Data Analysis
Descriptive statistics were used to
describe mean sample characteristics for age, sex, MDS-UPDRS III
score, H&Y stage, and balance performance. These values also were
determined separately for those who
dropped out of the study. Individuals
reporting 2 or more falls during
the analysis period of interest were
considered recurrent fallers.11 For
the retrospective analysis of the 6
months prior to baseline, we used
baseline fall history data. For the prospective analysis of the 6 months
following baseline, we used the
6-month follow-up fall history data.
For the prospective analysis of the
12 months following baseline, we
determined total fall count with
6-month and 12-month fall history
data. Participants who did not report
fall history at 6 or 12 months were

Hoehn & Yahr stage and MDS-UPDRS
III scores were collected at each
time point (baseline, 6 months, and
12 months), as was self-reported
6-month fall history, using a customdesigned form with a forced choice
response paradigm (ie, zero falls, 1
fall, 2–10 falls, weekly falls, or daily
falls). This form, along with the disease severity ratings, was administered by the same physical therapist
who conducted baseline assessments; however, to maintain blinding with respect to fall history, the
form was completed following the
administration of all other outcome
measures. Prior to completing the
form, each participant was informed
that a fall was defined as an unintentional event in which any part of the
body comes into contact with the
ground. This definition has been
used previously by investigators
studying fall prediction in people
with and without PD.19,20
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Table 1.
Baseline Demographic Characteristics of Participantsa
Variable

Entire Sample
(Nⴝ80)

Recurrent Fallers
(nⴝ25)

Those With <1 Fall
(nⴝ55)

68.2 (9.3)

69 (7.8)

68 (10)

Age (y)
Sex (n) (male/female)

47/33

16/9

31/24

MDS-UPDRS III score

41.3 (14.7)

52.6 (13.9)

36.2 (12.0)

I (4), II (27), II.5 (30), III (13), IV (6)

I (1), II (4), II.5 (11), III (5), IV (4)

I (4), II (27), II.5 (18), III (3), IV (3)

H&Y stage
Pretest probability of falling
(% recurrent fallers)
BESTest score

31.30%
70.4% (16.7%)

57.2% (15.3%)

76.4% (13.6%)

Mini-BESTest mean raw score
[percentage]b

20.2 (7.0) [63.1%]

14.3 (6.2) [44.7%]

22.9 (5.5) [71.5%]

Brief-BESTest mean raw score
[percentage]

13.2 (5.5) [55%]

8.9 (5.2) [37.1%]

15.2 (4.4) [63.3%]

a

Values are mean (SD). MDS-UPDRS III⫽Movement Disorder Society–Unified Parkinson’s Disease Rating Scale motor examination section, H&Y⫽Hoehn and
Yahr scale.
Mini-BESTest and Brief-BESTest percentage scores are included in brackets to allow comparison with BESTest scores.

b

not included in statistical analyses at
those respective time points.
Pearson correlation coefficients (r)
(␣⫽.05) were calculated to describe
relationships between: (1) the BriefBESTest and Mini-BESTest, (2) the
Brief-BESTest and full BESTest total
scores, and (3) the representative
Brief-BESTest item scores and their
respective BESTest subsection scores.
To compare fall prediction accuracy
of each outcome measure for each
time interval (ie, 6 months prior to
baseline, 0 – 6 months following
baseline, and 0 –12 months following
baseline), we created receiver operating characteristic (ROC) curves
and determined the area under the
curve (AUC) for each.21 Secondary
AUC analyses with just the 40 individuals who completed the full study
also were conducted. Empirical tests
of equivalence (2-tailed) were used
to make pair-wise comparisons of
AUCs (P⬍.05) in order to determine
whether an AUC of 1 measure was
different from that of another.22
From each ROC curve, we determined a cutoff score that maximized
sensitivity and specificity values and
calculated positive and negative likelihood ratios (LR⫹ and LR⫺) and
posttest probabilities for predicting
April 2013

falls. All statistical analyses were conducted using Number Cruncher Statistical System (NCSS) software.23
A power analysis was conducted as
a part of another study in which
81 participants were required to
describe the ability of the BESTest
and Functional Gait Assessment
(FGA) to retrospectively predict falls
in people with PD.16

Results
Eighty individuals (59% men and 41%
women) with idiopathic PD were
evaluated at baseline (Tab. 1). Of the
original sample of 80 there were 25
(31% men and 69% women) with a
retrospective history of 2 or more
falls in the past 6 months. From that
original sample, fall history data
were collected from 51 individuals
(14 recurrent fallers [27.5%]) at 6
months and from 40 individuals
(13 recurrent fallers [32.5%]) at 12
months. Scores (mean [SD]) for each
balance measure as well as disease
severity are provided in Table 1. Figure 1 depicts the number of participants evaluated at baseline, 6
months, and 12 months, as well as
the reasons for participant loss at
each time point. Seven (3 men and
4 women) of the 11 individuals who

were lost from 6 to 12 months were
characterized as recurrent fallers.
Demographic characteristics of
those who dropped out compared to
those who completed the full study
are provided in Table 2. On average,
participants who dropped out were
no different in terms of age or gender, but did have a higher percentage of recurrent fallers as defined at
baseline evaluation and had greater
disease severity (H&Y and MDSUPDRS III) when compared with
those who completed the full 12
months of the study. When comparing the available sample at each time
point across the study, however,
there were no significant changes in
disease severity or percentage of
recurrent fallers from baseline to 6 to
12 months.
Brief-BESTest Relationships
Brief-BESTest scores were significantly correlated with scores on the
Mini-BESTest and BESTest (r⫽.94,
P⬍.001, and r⫽.95, P⬍.001, respectively). Each item score on the BriefBESTest correlated with its respective section score on the full BESTest
(all P⬍.0001). The biomechanical
constraints (r⫽.61) and stability limits/verticality (r⫽.69) sections of the
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Brief-BESTest demonstrated the lowest correlations with their respective
sections of the BESTest. The highest
correlations between the BriefBESTest and BESTest sections were
for anticipatory postural adjustments
(r⫽.89) and postural responses (r⫽
.91), while sensory orientation (r⫽
.78) and stability in gait (r⫽.78) were
slightly less correlated.

Baseline
80 participants evaluated

Participants Lost at 6 Months=29
6 Months

•
•
•
•
•

Fall history obtained from 51
participants

Unable to contact (n=15)
Decline in condition (n=9)
Lack of transportation (n=1)
Family difficulties (n=1)
Incomplete data sets (n=3)

Participants Lost at 12 Months=40
12 Months

•
•
•
•
•

Fall history obtained from 40
participants

Unable to contact (n=19)
Decline in condition (n=12)
Lack of transportation (n=1)
Family difficulties (n=1)
Incomplete data sets (n=7)

Figure 1.
Flow diagram describing number of participants evaluated and reasons for loss at
designated time points.

Table 2.
Comparison of Baseline Characteristics Between Participants Who Did or Did Not
Drop Out at 12 Monthsa
Variable
% Recurrent fallers
Age (y)
Sex (% male/% female)
H&Yb

Did Not Drop Out
(nⴝ40)

Dropped Out
(nⴝ40)

P

20

43

.03

67.3 (9.5)

69.1 (9.1)

.4

40/60

43/57

.8

2.2 (0.6)

2.6 (0.7)

.004

MDS-UPDRS III

37.8 (13.1)

44.9 (15.4)

.03

BESTest score

75.4 (13.5)

65.5 (18.2)

.007

Mini-BESTest score

22.4 (6.1)

18.1 (7.3)

.005

Brief-BESTest score

14.7 (4.7)

11.7 (5.9)

.01

a

Values are mean (SD). Independent samples t tests were conducted unless otherwise indicated.
MDS-UPDRS III⫽Movement Disorder Society–Unified Parkinson’s Disease Rating Scale motor
examination section, H&Y⫽Hoehn and Yahr scale.
b
Mann-Whitney U test was used for differences.
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Fall Prediction Using the
Brief-BESTest
The ROC curves for the 3 measures
are presented in Figure 2. Details of
the predictive abilities of the BriefBEST at all 3 time points are presented in Table 3. These same values
for the Mini-BESTest and BESTest
have been reported previously for
this sample.10,11 Retrospectively, the
Brief-BESTest had the highest posttest probability of falling with a score
less than or equal to the cutoff when
compared with the BESTest and
Mini-BESTest. Also at this time point,
the LR⫹ for the Brief-BESTest
exceeded those of the other measures. At 6 months, the highest LR⫹
and lowest LR⫺ were derived from
the BESTest (Tab. 3). The LR⫹ for
the Brief-BESTest was 5.29, and the
LR⫺ was the highest of the 3 measures. Pretest probability of falling
at 6 months was 27.5%, and after
administration of the 3 measures, the
posttest probability of falling was
60% or higher for each test at 6
months, with the BESTest highest at
69%. At 12 months, predictive values
for most measures were lower than
at 6 months (Tab. 3).
Regarding comparisons between
the Brief-BESTest, Mini-BESTest, and
BESTest when used to retrospectively predict falls, equivalence tests
of the AUCs revealed no significant
differences between the 3 balance
tests for retrospective or prospective
fall prediction across 6 or 12 months.
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Discussion
To our knowledge, this is the first
study to describe balance performance as assessed by the BriefBESTest in people with PD. This
newly derived balance assessment
includes items from each of the 6
systems examined using the original
full BESTest, as opposed to the MiniBESTest, which only includes items
from 4 of the 6 systems.13
Total scores from each test were
strongly related to one another, supporting our hypothesis. Perhaps the
most interesting relationship was
that between the Brief-BESTest and
Mini-BESTest. The strength of the
correlation suggests that overall
the Brief-BESTest and Mini-BESTest
result in similar outcomes despite
the fact that items are included in
the Brief-BESTest from the 2 systems
not examined with the Mini-BESTest.
Interestingly, the 2 systems tested
in the Brief-BESTest that are not
included in the Mini-BESTest had
lower correlations with scores from
those systems in the full BESTest.
There are some potential explanations for the lower correlations.
First, it is possible that these 2 systems are either inadequately tested
with the items in the full BESTest or
that these systems have less impact
on the overall balance score on the
Brief-BESTest among people with
PD. Second, it is important to note
the heterogeneity between items
within both of these BESTest sections, such as body alignment and
postural transition items contained
in the same section as ankle and hip
strength items. Third, both of these
sections are the least reliable in the
BESTest examination; however, it is
important to note that the BriefBESTest items representing these
sections have higher reliability than
other items in those sections.9
Finally, it is possible that the items in
the Brief-BESTest representing these
2 balance systems may not be the
best items to detect impairments in
April 2013

Figure 2.
Receiver operating characteristic (ROC) curves for the Brief-BESTest, Mini-BESTest, and
BESTest for retrospective fall prediction over 6 months (A) and prospective fall prediction over 6 months (B) and 12 months (C).
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Values are mean (SD). Values inside brackets indicate percentage score determined from raw score to ease comparison to the BESTest. AUC⫽area under the curve, 95% CI⫽95% confidence interval,
LR⫹⫽positive likelihood ratio, LR⫺⫽negative likelihood ratio.

26.0%
46.0%
32.5%
0.73 (0.59–0.91)
1.77 (1.19–2.62)
0.46 (0.20–0.74)
ⱕ69%
0.68 (0.45–0.83)

a

Prospective (12 mo)

0.93 (0.64–0.99)

0.74 (0.57–0.91)

3.0%

8.7%
61.3%

69.0%
27.5%

31.0%
0.21 (0.09–0.52)

0.08 (0.04–0.17)
5.81 (3.69–9.14)

3.49 (2.11–5.77)
0.76 (0.62–0.86)
0.84 (0.63–0.95)

0.89 (0.74–0.95)
Prospective (6 mo)

ⱕ69%

0.84 (0.75–0.93)
Retrospective (6 mo)

ⱕ69%

0.84 (0.67–0.93)

20.0%
53.0%
32.5%
0.52 (0.39–0.68)
2.37 (1.66–3.34)
0.62 (0.32–0.85)
0.77 (0.55–0.89)
BESTest

Prospective (12 mo)

ⱕ20/32 [62.5%]

0.74 (0.53–0.88)

7.0%

6.5%
64.7%

60.0%
27.5%

31.0%
0.15 (0.05–0.45)

0.18 (0.11–0.78)
3.97 (2.68–5.70)

4.03 (2.40–6.79)

0.86 (0.56–0.97)

0.78 (0.64–0.88)
0.88 (0.68–0.97)

0.87 (0.72–0.94)
Prospective (6 mo)

ⱕ20/32 [62.5%]

0.86 (0.76–0.95)
Retrospective (6 mo)

ⱕ20/32 [62.5%]

0.78 (0.61–0.90)

19.4%
77.8%
32.5%
0.50 (0.27–0.91)
7.27 (1.75–30.24)
0.53 (0.26–0.80)
ⱕ11/24 [45.8%]
0.76 (0.51–0.89)
Mini-BESTest

0.71 (0.42–0.90)

Prospective (12 mo)

0.76 (0.54–0.90)

ⱕ11/24 [45.8%]

0.82 (0.69–0.90)

0.88 (0.74–.0.94)
Prospective (6 mo)

Brief-BESTest

Retrospective (6 mo)

ⱕ11/24 [45.8%]

0.93 (0.74–0.99)

11.2%

11.5%
67.8%

66.9%
27.5%

31.0%
0.29 (0.14–0.58)
4.64 (2.46–8.78)
0.84 (0.71–0.92)

0.33 (0.14–0.76)

LRⴚ (95% CI)
LRⴙ (95% CI)
Sensitivity
(95% CI)
Time Point

AUC (95% CI)

Score

Specificity
(95% CI)

5.29 (2.19–12.74)

Posttest
Probability
With Test
<Cutoff
Value
Pretest
Probability
of Falling
Before
Assessment

Predictive Values for the Brief-BESTest, Mini-BESTest, and BESTest at Each Time Pointa

Table 3.
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0.87 (0.70–0.95)

Posttest
Probability
With Test
>Cutoff
Value
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their respective domains in people
with PD.
To determine whether the BriefBESTest would be an appropriate
and equally valuable examination
tool in detecting fall risk in people
with PD, we evaluated its accuracy
in retrospectively and prospectively
predicting who would fall in a given
time period. The Brief-BESTest
(AUC⫽0.82) compared well with
the Mini-BESTest and BESTest
(AUC⫽0.86 and 0.84, respectively)
for identifying recurrent fallers based
on retrospective fall reports over the
previous 6 months10 and for prospective identification of recurrent
fallers over 6 and 12 months. Accuracy of all 3 measures was less than
ideal over the 12-month prospective
period. Sensitivity for all 3 tests
ranged from 0.46 (BESTest) to 0.62
(Mini-BESTest).10 At 12 months, the
posttest probability of falling with a
score greater than the proposed
cutoff was between 19.4% (BriefBESTest) and 26% (BESTest), suggesting that approximately 1 of 5 individuals identified as not at risk for falls
would fall in the next 12 months.11
The negative posttest probability at
6 months ranged from 3% (BESTest)
to 11.2% (Brief-BESTest), indicating
that any of the balance assessments
at 6-month intervals are more likely
to accurately identify individuals
with PD at risk for falls as compared
with assessments performed on a
yearly basis.10
Other investigators have studied outcome measures and their ability to
prospectively predict falls in people
with PD. A meta-analysis of 6 studies
revealed that a prior history of 2 or
more falls in the previous year, not
MDS-UPDRS score, was the best predictor of falls over the next 3
months.24 This finding may lead to
skepticism regarding why a clinician
would take time to complete balance
assessments instead of simply asking
for fall history if both are equally
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accurate predictors of future falls.
We think that, although it is a useful
predictor of falls, fall history can be
unreliable and does not provide
information to clinicians concerning
the cause of the falls.25 As such, clinicians would have no information
on which to base their rehabilitation
treatment in an attempt to reduce
the likelihood of future falls.
Mak and Pang26 noted that the
Activities-specific Balance Confidence Scale (ABC) had an AUC of
0.82, a sensitivity of 0.93, and a specificity of 0.67 when attempting to
prospectively predict falls over the
next 12 months in people with PD.
Perhaps the biggest limitation in this
outcome measure is that it requires
subjective responses, which could
be unreliable in the PD population.
Second, if used alone, the therapist
would be provided no physically
objective data from the ABC and
would not gain insight into a potential mechanism for falls that could
be used to guide treatment. Kerr and
colleagues27 prospectively studied
fall predictors over 6 months in people with PD and noted that commonly used outcome measures were
not good predictors of falls when
used alone. Notably, the Tinetti total
score (AUC⫽0.72, sensitivity⫽0.67,
and specificity⫽0.59), the Berg Balance Scale (BBS) (AUC⫽0.61, sensitivity⫽0.65, and specificity⫽0.51),
and the Timed “Up & Go” Test
(AUC⫽0.65, sensitivity⫽0.69, and
specificity⫽0.62) all demonstrated
worse predictive ability than all 3
versions of the BESTest noted in the
present study at 6 months.27 Finally,
the FGA did not perform as well as
the BESTest and Mini-BESTest when
used to determine prospective fall
risk in people with PD.11 We speculate that the BESTest, Mini-BESTest,
and Brief-BESTest may be more accurate for fall prediction than these
measures due to the fact that they
are essentially batteries of tests measuring more than 1 factor related to
April 2013

falling. Because falls are multifactorial in nature, it might be best to
measure as many constructs related
to falling rather than focusing on 1
construct.
Identification of the BESTest, MiniBESTest, and Brief-BESTest as being
accurate in predicting future falls in
PD is vital so that, with these measures, clinicians can detect fall risk
before a fall occurs and implement
effective rehabilitation programs for
people with PD, with the goal of
preventing falls.7,8 Because the BriefBESTest and Mini-BESTest are used to
assess the validity of constructs associated with fall risk, are accurate in
predicting future falls, and can be
completed in a clinically reasonable
amount of time, we suggest their use
so that clinicians can determine
which constructs should be targeted
in physical rehabilitation. Although
the BESTest outperformed the MiniBESTest and Brief-BESTest at 6
months and optimally would be used
for fall risk assessment in PD, time
constraints in daily practice may not
permit its use. As such, we think
sacrificing a small amount of accuracy by using the Mini-BESTest or
Brief-BESTest is reasonable when
time does not permit administration
of the full BESTest.
Study Limitations
The interpretation of results from
this study should be tempered by
the following limitations. The cutoff
score for the Brief-BESTest is meant
only to assist clinical decision making. Because there are false positives
and false negatives with any of the 3
balance tests, cutoff scores should
not be considered definitive points
to classify individuals as likely recurrent fallers. The sample included
primarily individuals with mild to
moderate PD, which limits generalizability to the overall population
with PD. As these findings are specific to PD, investigators should compare these outcome measures across

other populations and study their
usefulness with respect to other variables of interest other than falls.
Assessments took place only with
participants on antiparkinson medication. It is unclear whether the
accuracy of fall prediction using the
3 versions of the test would have
changed if participants were
assessed off antiparkinson medication. If falls are more common during times when medications are
not working effectively, one might
expect off-medication testing to
yield better predictive results. This
is an important area for future
research. Future studies also should
track falls on shorter time intervals
(eg, daily or weekly) through a falls
diary or phone interviews. This
approach would likely enhance fall
reporting and be superior to the retrospective reporting method used in
the present study. Finally, the dropout rates from baseline to 6 and 12
months were moderate at 36% and
49% of the original sample, respectively, resulting in sample sizes at 6
and 12 months that did not meet the
requirements of our power analysis.
As many of the individuals dropping
out were considered recurrent fallers, it is unclear how this factor
might have affected our data had
they remained in the study. However, our data suggest that disease
severity of the samples was consistent across time points. We also conducted secondary ROC curve analyses for baseline and 6 months of only
the 40 individuals who completed
the full 12 months of the study, and
our results (not reported) did not
change, further suggesting that dropout of individuals may not have substantially affected our results.

Conclusion
The BESTest, Mini-BESTest, and
Brief-BESTest are valuable measures
to assess fall risk in PD. If equipment
or time is limited, clinicians may prefer the Brief-BESTest. Given the limited ability to prospectively predict
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falls over a 1-year time period, we
recommend that balance testing
should be conducted every 6 months
for people with PD.
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